Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now NasdaqCM - Delayed Quote • USD Pasithea Therapeutics Corp. (KTTAW) Follow Compare 0.0182 0.0000 (0.00%) At close: March 25 at 4:00:00 PM EDT Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for KTTAW 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: KTTAW View More All News Press Releases SEC Filings Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer Pasithea Therapeutics Announces Opening of European Clinical Trial Sites and Completes Initial Dosing of Cohort 4 Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules Sector Update: Health Care Stocks Mixed Late Afternoon Top Midday Gainers Why Is Pasithea Therapeutics Stock Surging On Thursday? Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference